Latest News | Jul 6, 2021

ICYMI: New Campaign Calls Out Reps. Peters And Valadao For Threatening To Block Medicare Negotiation Legislation

CALIFORNIA — Patients For Affordable Drugs Now launched a campaign calling out Reps. Scott Peters (CA-52) and David Valadao (CA-21) for threatening to block Medicare negotiation bill H.R. 3, and calling on them to support the legislation that would lower drug prices for Californians. The patient advocacy group also extended its campaign thanking Reps. Josh Harder (CA-10) and Mike Levin (CA-49) and urging Reps. Tony Cárdenas (CA-29) and Lou Correa (CA-46) to support H.R. 3. The campaigns include TV ads, digital ads, and grassroots advocacy, in which patients will write and call their members of Congress directly asking them to support plans to allow Medicare to negotiate lower drug prices — a policy supported by 90 percent of Americans. 

“Reps. Peters and Valadao have a choice — they can continue to do the bidding of Big Pharma, or they can stand with California patients by supporting Medicare negotiation and H.R. 3,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Instead, they are currently attempting to block legislation that could save the lives of 94,000 Americanseach year. As Therese Ball, a multiple sclerosis patient, says in the ad, ‘It’s unforgivable.’ Reps. Peters and Valadao can still do the right thing and stand up to Big Pharma by endorsing H.R. 3, which will deliver the innovation we need at prices we can afford.”

Reps. Peters and Valadao have both refused to support H.R. 3, a bill that would allow Medicare to negotiate lower drug prices. Rep. Peters touted his support for the bill in 2019 but more recently has come out in opposition, even threatening to derail his party’s budget bill if it includes the legislation. Rep. Valadao has taken over $100,000 from pharmaceutical manufacturers over his years in Congress and refuses to take any stance on drug pricing policy, including H.R. 3.

“Rep. Peters supported H.R. 3 before receiving over $239,000 in contributions from the pharmaceutical and health products industry. Now he opposes H.R. 3; voters can draw their own conclusions about his motivations,” Mitchell said.

The campaign kicks off with videoads featuring multiple sclerosis patient and registered nurse Therese Ball from Ogden Dunes, Indiana. To manage her symptoms, Ball is prescribed Tysabri, which is priced at $7,463 each month. 

“As a nurse, I had patients who struggled to pay for their prescription drugs. When I was diagnosed with MS, I became one, too. The medications I need to live are priced at over $7,000 a month,” Ball, a grandmother and retired nurse, says in the video ads. “Members of Congress are choosing Big Pharma over patients. It’s unforgivable.” 

Watch the ad for Rep. Scott Peters (CA-52) here
Watch the ad for Rep. David Valadao (CA-21) here.

P4ADNow also launched ads calling out Reps. Richard Hudson (NC-08) and Kurt Schrader (OR-05), who have refused to endorse H.R. 3.

P4ADNow launched its first campaign directed towards the 117th Congress on May 20. The national campaign had a seven-figure budget and called for support of H.R. 3 in 42 House districts across 22 states and in D.C. It expandedlast week, adding two more House districts. The campaign is, in part, a counterweight to Big Pharma’s attack ads loaded with lies about H.R. 3 and includes video ads, digital ads, and grassroots advocacy.

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, was reintroducedin the House of Representatives in April. The chamber passed the bill in the 116th Congress. It will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.

###

OREGON — Patients For Affordable Drugs Now announced the launch of a campaign calling out Rep. Kurt Schrader (OR-05) for threatening to block Medicare negotiation bill H.R. 3, and calling on him to support the legislation that would lower drug prices for Americans. The new push began on July 2 and includes TV ads, digital ads, and grassroots advocacy, in which patients will write and call Rep. Schrader directly asking him to support plans to allow Medicare to negotiate lower drug prices. 

“Rep. Schrader has a choice — he can continue to do the bidding of Big Pharma, or he can stand with patients by supporting Medicare negotiation and H.R. 3,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Right now, Rep. Schrader is attempting to block legislation that could save the lives of 94,000 Americans each year. As Therese Ball, a multiple sclerosis patient, says in the ad, ‘It’s unforgivable.’ But he can still do the right thing by endorsing H.R. 3, which will deliver the innovation we need at prices we can afford.”

Rep. Schrader has refused to support H.R. 3, a bill that would allow Medicare to negotiate lower drug prices, in this Congress. He originally said he was proud of his vote in support of H.R. 3 in 2019, but since then has raised concerns about the legislation, even suggesting Congress take a less “robust”approach to drug pricing reform, contrary to the wishes of 90 percent of Americans. 

The campaign kicks off with a new video ad featuring multiple sclerosis patient and registered nurse Therese Ball from Ogden Dunes, Indiana. To manage her symptoms, Ball is prescribed Tysabri, which is priced at $7,463 each month. 

“As a nurse, I had patients who struggled to pay for their prescription drugs. When I was diagnosed with MS, I became one, too. The medications I need to live are priced at over $7,000 a month,” Ball, a grandmother and retired nurse, says in the video ads. “Members of Congress are choosing Big Pharma over patients. It’s unforgivable.” 

“Ninety percent of Americans want Medicare to negotiate lower drug prices, but Rep. Kurt Schrader is working to block it,” the ad says. “Tell him to do the right thing and support the Lower Drug Costs Now Act.”

Watch the video ad here and view the static ad below: 

P4ADNow also launched similar ads calling out Reps. David Valadao (CA-21)Scott Peters (CA-52), and Richard Hudson (NC-08), who have also refused to endorse H.R. 3.

P4ADNow launched its first campaign directed towards the 117th Congress on May 20. The national campaign had a seven-figure budget and called for support of H.R. 3 in 42 House districts across 22 states and in D.C. It expandedlast week, adding two more House districts. The campaign is, in part, a counterweight to Big Pharma’s attack ads loaded with lies about H.R. 3 and includes video ads, digital ads, and grassroots advocacy.

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, was reintroducedin the House of Representatives in April. The chamber passed the bill in the 116th Congress. It will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.

###

NORTH CAROLINA — Patients For Affordable Drugs Now announced the launch of a campaign calling out Rep. Richard Hudson (NC-08) for opposing Medicare negotiation bill H.R. 3, and calling on him to support the legislation that would lower drug prices for Americans. The patient advocacy group also extended its existing grassroots campaign, in which patients will contact Reps. Deborah Ross (NC-02) and Kathy Manning (NC-06) to thank them for supporting the legislation. 

“Rep. Hudson has a choice — he can continue to do the bidding of Big Pharma, or he can stand with patients by supporting Medicare negotiation and H.R. 3,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Instead, he is attempting to block legislation that could save the lives of 94,000 Americans each year. As Therese Ball, a multiple sclerosis patient, says in the ad, ‘It’s unforgivable.’ Rep. Hudson can still do the right thing by endorsing H.R. 3, which will deliver the innovation we need at prices we can afford.”

Rep. Hudson took more money from pharma than any other member of the House of Representatives during the 2020 election cycle. As a member of the House Energy and Commerce Health Subcommittee, he has taken many opportunities to attackH.R. 3

The campaign kicks off with a new video ad featuring multiple sclerosis patient and registered nurse Therese Ball from Ogden Dunes, Indiana. To manage her symptoms, Ball is prescribed Tysabri, which is priced at $7,463 each month. 

“As a nurse, I had patients who struggled to pay for their prescription drugs. When I was diagnosed with MS, I became one, too. The medications I need to live are priced at over $7,000 a month,” Ball, a grandmother and retired nurse, says in the video ads. “Members of Congress are choosing Big Pharma over patients. It’s unforgivable.” 

Ninety percent of Americans want Medicare to negotiate lower drug prices, but Rep. Kurt Schrader is working to block it,” the ad says. “Tell him to do the right thing and support the Lower Drug Costs Now Act.”

Watch the video ad here.

P4ADNow also launched similar ads calling out Reps. David Valadao (CA-21)Scott Peters (CA-52), and Kurt Schrader (OR-05), who have also refused to endorse H.R. 3.

P4ADNow launched its first campaign directed towards the 117th Congress on May 20. The national campaign had a seven-figure budget and called for support of H.R. 3 in 42 House districts across 22 states and in D.C. It expandedlast week, adding two more House districts. The campaign is, in part, a counterweight to Big Pharma’s attack ads loaded with lies about H.R. 3 and includes video ads, digital ads, and grassroots advocacy.

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, was reintroducedin the House of Representatives in April. The chamber passed the bill in the 116th Congress. It will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.

###

WASHINGTON, D.C. — The following statement was issued today by Patients For Affordable Drugs Now: 

“We want to thank Senator Casey’s office for engaging in conversations with us and reiterating his long-standing support for Medicare negotiation. We appreciate his continuing commitment to a strong Senate Finance Committee drug pricing bill, including an effective approach to Medicare negotiation that will lower prices for Americans. As a result, we are suspending advertising and other activities in Pennsylvania that were announced yesterday. We regret any misunderstandings on our part and look forward to working with Senator Casey and his office to achieve our mutual goals in the weeks and months ahead.”

###

WASHINGTON, D.C. — Patients For Affordable Drugs Now today announced the launch of a campaign aimed at members of the House of Representatives who are threatening to block Medicare negotiation bill H.R. 3, calling on them to support the legislation that would lower drug prices for Americans. The new six-figure push begins on July 2 and includes TV ads, digital ads, and grassroots advocacy, in which patients will write and call their members of Congress directly asking them to support plans to allow Medicare to negotiate lower drug prices — a policy supported by 90 percent of Americans. The new campaign will address Reps. David Valadao (CA-21), Scott Peters (CA-52), Richard Hudson (NC-08), and Kurt Schrader (OR-05), all of whom have refused to endorse H.R. 3.

“Reps. Valadao, Peters, Hudson, and Schrader have a choice — they can continue to do the bidding of Big Pharma, or they can stand with patients by supporting Medicare negotiation and H.R. 3,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Right now, it’s clear that the congressmen are choosing Big Pharma’s interests over the well-being of patients. As Therese Ball, a multiple sclerosis patient, says in the ad, ‘It’s unforgivable.’ Each of these elected officials can still do the right thing by endorsing H.R. 3, which will deliver the innovation we need at prices we can afford.”

All four members of Congress have refused to support H.R. 3, a bill that would allow Medicare to negotiate lower drug prices: 

The campaign kicks off with ads featuring multiple sclerosis patient and registered nurse Therese Ball from Ogden Dunes, Indiana. To manage her symptoms, Ball is prescribed Tysabri, which is priced at $7,463 each month. 

“As a nurse, I had patients who struggled to pay for their prescription drugs. When I was diagnosed with MS, I became one, too. The medications I need to live are priced at over $7,000 a month,” Ball, a grandmother and retired nurse, says in the video ads. “Members of Congress are choosing Big Pharma over patients. It’s unforgivable.” 

Watch the ad for Rep. David Valadao (CA-21) here
Watch the ad for Rep. Scott Peters (CA-52) here
Watch the ad for Rep. Richard Hudson (NC-08) here.
Watch the ad for Rep. Kurt Schrader (OR-05) here.

P4ADNow launched its first campaign directed towards the 117th Congress on May 20. That campaign had a seven-figure budget and called for support of H.R. 3 in 42 House districts across 22 states and in D.C. It expanded this week, adding two more House districts. The campaign is, in part, a counterweight to Big Pharma’s attack ads loaded with lies about H.R. 3 and includes video ads, digital ads, and grassroots advocacy.

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, was reintroducedin the House of Representatives in April. The chamber passed the bill in the 116th Congress. It will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.

###

COLORADO — The following statement was issued today by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now: 

“We want to thank Senator Bennet’s office for the opportunity to have a conversation today, during which we clarified his position on drug price legislation. We received strong assurances of Senator Bennet’s continued commitment to fighting for a strong Senate Finance Committee drug pricing bill that will include an effective approach to Medicare negotiation that will lower prices and reduce out-of-pocket costs for patients and all Americans. As a result, we are suspending advertising and other activities in Colorado that were announced today. We regret any misunderstandings on our part, and we look forward to working with Senator Bennet and his office to achieve our mutual goals in the weeks and months ahead.”

###

WASHINGTON, D.C. — Patients For Affordable Drugs Now announced the launch of a campaign encouraging members of the Senate Finance Committee to support legislation to lower drug prices by allowing Medicare negotiation. The new six-figure push will begin on July 2 and includes TV ads, digital ads, and grassroots advocacy, in which patients will write and call their senators directly. The Senate campaign addresses Senators Tom Carper (D-DE) and Bob Menendez (D-NJ).

“As the Senate Finance Committee develops detailed legislative proposals built on the excellent principles promulgated by Chairman Wyden, it’s critical for Senators Carper and Menendez to bear in mind that 90 percent of Americans support Medicare negotiation to lower drug prices,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Patients are depending on these senators to join with other supporters of meaningful reform and insist on strong legislation that will lower drug prices and deliver savings for Medicare beneficiaries and all Americans.”

Senate Finance Committee Chairman Ron Wyden recently released his guiding principles for drug pricing reform. It is expected that the Finance Committee’s bill will be considered for inclusion in the Democrats’ reconciliation budget package later this year. 

The campaign includes new video ads featuring multiple sclerosis patient and registered nurse Therese Ball from Ogden Dunes, Indiana. To manage her symptoms, Ball is prescribed Tysabri, which is priced at $7,463 each month. 

“As a nurse, I had patients who struggled to pay for their prescription drugs. When I was diagnosed with MS, I became one, too. The medications I need to live are priced at over $7,000 every month,” Ball, a grandmother and retired nurse, says in the video ads. “I can’t afford these prices. I had to ration and skip doses.” 

The ads urge each senator to support legislation to allow Medicare to negotiate prices. “Patients need this reform, and we need his support,” the ads say. 

Watch the ad for Senator Tom Carper (D-DE) here.
Watch the ad for Senator Bob Menendez (D-NJ) here

This campaign marks the launch of P4ADNow’s outreach to senators in the 117th Congress. It complements the patient advocacy group’s House campaign to support H.R. 3 first launched on May 20 with a seven-figure budget to 42 House districts across 22 states and in D.C, which then expanded to add two more House districts. This campaign is, in part, a counterweight to Big Pharma’s attack ads loaded with lies about H.R. 3 and included video ads, digital ads, and grassroots advocacy.

###

NEW YORK — Patients For Affordable Drugs Now announced it will extend its campaign thanking Reps. Sean Patrick Maloney (NY-18) and Antonio Delgado (NY-19) for supporting H.R. 3 and calling on Rep. Kathleen Rice (NY-04) to support the bill that would lower drug prices by allowing Medicare to negotiate on behalf of New Yorkers. The new phase of the campaign will start July 2 and will include digital ads as well as grassroots advocacy, in which constituents will directly contact Reps. Maloney, Delgado, and Rice to ask them to stand with patients against Big Pharma.

“H.R. 3 will ensure New Yorkers have access to affordable medicine while protecting innovation for the future,” said David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now. “Patients need Rep. Rice to stand up to Big Pharma and join Reps. Maloney and Delgado in pushing for this important legislation to lower the price of prescription drugs for Americans.”

The following digital ad will run in NY-18 to thank Rep. Maloney for standing with patients and to remind him to push for passage of H.R. 3. 

The following digital ad will run in NY-04 to urge Rep. Rice to stand with patients and push for passage of H.R. 3. 

P4ADNow’s campaign to support H.R. 3 was first launched on May 20 on the heels of Big Pharma’s attack ads loaded with lies, pressuring members of Congress not to support H.R. 3.

H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act, was reintroducedin the House of Representatives in April. The chamber passed the bill in the 116th Congress. It will lower prices, rein in price gouging, and reduce out-of-pocket costs by restoring balance to the U.S. drug pricing system to ensure both innovation and affordability.

The New York campaign is part of Patients For Affordable Drugs Now’s national campaign across 44 House districts.

###